Christopher Nathan Martin's most recent trade in Edgewise Therapeutics Inc was a trade of 45,150 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Nov. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics Inc | Christopher Nathan Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2025 | 45,150 | 45,150 | - | - | Stock Options (Right to buy) |